版本:
中国

BRIEF-Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor

May 12 Ardelyx Inc:

* Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor in patients with IBS-C

* Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor in patients with IBS-C

* Ardelyx Inc - study achieves primary endpoint

* Ardelyx Inc - tenapanor was well-tolerated, consistent with experience across previous clinical trials

* Says it plans to assess the data alongside results from t3mpo-2, co's six-month phase 3 study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐